Back to results
US 2012/0251440 A1Published application
Methods of myocardial perfusion imaging
AssigneeGilead Sciences, Inc.
InventorsLuiz Belardinelli, Brent K. Blackburn, Zhenhai Gao
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for identifying and using partial adenosine A2A receptor agonists that are useful as adjuncts in myocardiological perfusion imaging.
Claims4
1-14. (canceled)
A method of myocardial perfusion imaging in a human in need thereof comprising:
- administering to the human (a) CVT-3146, also known as (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide, in an amount of 0.2 to 9 μg/kg by a single intravenous bolus dose of a liquid pharmaceutical composition comprising CVT-3146 and (b) a radionuclide, and thereafter determining areas of insufficient blood flow.
Dependencies are inferred from the claim text.